Combination therapy of potential gene to enhance oral cancer therapeutic effect

Chia-Hsien Yeh; Yih-Chih Hsu

doi:10.1117/12.2081129

9 March 2015 Combination therapy of potential gene to enhance oral cancer therapeutic effect

Chia-Hsien Yeh, Yih-Chih Hsu

Proceedings Volume 9324, Biophotonics and Immune Responses X; 932417 (2015) https://doi.org/10.1117/12.2081129
Event: SPIE BiOS, 2015, San Francisco, California, United States

Abstract

The epidermal growth factor receptor (EGFR) over-regulation related to uncontrolled cell division and promotes progression in tumor. Over-expression of human epidermal growth factor receptor (EGFR) has been detected in oral cancer cells. EGFR-targeting agents are potential therapeutic modalities for treating oral cancer based on our in vitro study. Liposome nanotechnology is used to encapsulate siRNA and were modified with target ligand to receptors on the surface of tumor cells. We used EGFR siRNA to treat oral cancer in vitro.

Citation Download Citation

Chia-Hsien Yeh and Yih-Chih Hsu "Combination therapy of potential gene to enhance oral cancer therapeutic effect", Proc. SPIE 9324, Biophotonics and Immune Responses X, 932417 (9 March 2015); https://doi.org/10.1117/12.2081129

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available